Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: UNIVERSITY OF OKLAHOMA
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-25 to 2028-03-24
Current total value of award: $1234179
Description: BASE IDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS  TASK ORDER TITLE: FURTHER DEVELOPMENT OF MITOCHONDRIA-TARGETED HONOKIOL FOR PREVENTION OF LUNG CANCER: ADENOCARCINOMA A